Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO MAP 2022 | Validating the source of malignant mutations

Andrea Degasperi • 12 Oct 2022
ESMO MAP 2022
General

Andrea Degasperi, PhD, University of Cambridge, Cambridge, UK, discusses the significance of identifying the source of cancerous mutations to help to identify the optimal approach to treating the cancer. This interview took place at the Molecular Analysis for Precision oncology (MAP) Congress 2022 in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Andrea Degasperi

1:45
Whole-genome analysis of more than 12,000 tumors reveals new insight into the cause of cancer
Andrea Degasperi • 12 Oct 2022
2:27
Genomic analysis of environmental impact on cancer risk
Andrea Degasperi • 12 Oct 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals